F Maggiolo

1.7k total citations
17 papers, 263 citations indexed

About

F Maggiolo is a scholar working on Pediatrics, Perinatology and Child Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, F Maggiolo has authored 17 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in F Maggiolo's work include HIV/AIDS Research and Interventions (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and HIV Research and Treatment (2 papers). F Maggiolo is often cited by papers focused on HIV/AIDS Research and Interventions (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and HIV Research and Treatment (2 papers). F Maggiolo collaborates with scholars based in Italy, United States and Germany. F Maggiolo's co-authors include Fredy Suter, Dario Conte, Aurelio Sonzogni, Flavio Caprioli, Daniele Prati, E. Minola, Silvia Paggi, Mirella Fraquelli, Riccardo Coletta and Maria Grazia Finazzi and has published in prestigious journals such as Blood, Critical Care Medicine and Journal of Antimicrobial Chemotherapy.

In The Last Decade

F Maggiolo

17 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Maggiolo Italy 9 146 121 60 39 37 17 263
Lana Kosi Austria 8 136 0.9× 73 0.6× 33 0.6× 10 0.3× 20 0.5× 11 370
Anela Kellogg United States 8 93 0.6× 22 0.2× 116 1.9× 14 0.4× 7 0.2× 8 264
Ricky Hsu United States 9 64 0.4× 50 0.4× 161 2.7× 85 2.2× 30 0.8× 20 255
Kamila Wójcik Poland 10 138 0.9× 69 0.6× 81 1.4× 42 1.1× 2 0.1× 33 255
Bernard Surial Switzerland 9 87 0.6× 65 0.5× 87 1.4× 45 1.2× 2 0.1× 21 209
María Jesús Jiménez‐Expósito United States 8 162 1.1× 163 1.3× 67 1.1× 34 0.9× 2 0.1× 12 266
Line Meddeb France 8 73 0.5× 12 0.1× 174 2.9× 42 1.1× 13 0.4× 15 345
S. W. Schalm Netherlands 12 220 1.5× 245 2.0× 22 0.4× 6 0.2× 7 0.2× 21 330
G. Elia Italy 8 102 0.7× 125 1.0× 15 0.3× 23 0.6× 3 0.1× 18 288
Maurizio D’Abbraccio Italy 7 48 0.3× 23 0.2× 145 2.4× 63 1.6× 5 0.1× 13 260

Countries citing papers authored by F Maggiolo

Since Specialization
Citations

This map shows the geographic impact of F Maggiolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Maggiolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Maggiolo more than expected).

Fields of papers citing papers by F Maggiolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Maggiolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Maggiolo. The network helps show where F Maggiolo may publish in the future.

Co-authorship network of co-authors of F Maggiolo

This figure shows the co-authorship network connecting the top 25 collaborators of F Maggiolo. A scholar is included among the top collaborators of F Maggiolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Maggiolo. F Maggiolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Taramasso, Lucia, F Maggiolo, Daniela Valenti, et al.. (2025). Adherence and Forgiveness of Two Modern ART Regimens: Lamivudine/Dolutegravir and Emtricitabine/Tenofovir Alafenamide/Rilpivirine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 98(5). 484–490. 1 indexed citations
2.
Focà, Emanuele, Massimiliano Fabbiani, Mattia Prosperi, et al.. (2016). Liver fibrosis progression and clinical outcomes are intertwined. Medicine. 95(29). e4091–e4091. 16 indexed citations
3.
Gazzard, Brian, Shehzad Ali, Axel Mühlbacher, et al.. (2014). Patient preferences for characteristics of antiretroviral therapies: results from five European countries. Journal of the International AIDS Society. 17(4S3). 19540–19540. 14 indexed citations
4.
Rosso, Raffaella, Antonio Di Biagio, F Maggiolo, et al.. (2011). Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen. AIDS Care. 24(1). 54–58. 13 indexed citations
5.
Minola, E., Daniele Prati, Fredy Suter, et al.. (2002). Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood. 99(12). 4588–4591. 113 indexed citations
6.
Maggiolo, F, et al.. (2001). Gabapentin in painful HIV‐related neuropathy: a report of 19 patients, preliminary observations. European Journal of Neurology. 8(1). 71–75. 22 indexed citations
7.
Arici, Claudio, Diego Ripamonti, Veronica Ravasio, et al.. (2001). Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution. International Journal of STD & AIDS. 12(9). 573–581. 23 indexed citations
8.
Locati, P, et al.. (2000). Management of infected peripheral bypass by selective partial graft removal and arterial homograft insertion. Two case reports.. PubMed. 41(2). 311–5. 2 indexed citations
9.
Maggiolo, F, et al.. (1990). Risk/benefit analysis of quinolone use in children: the effect on diarthrodial Joints. Journal of Antimicrobial Chemotherapy. 26(4). 469–471. 13 indexed citations
10.
Maggiolo, F, et al.. (1989). Theophylline overdose or pharmacological interaction?. BMJ. 298(6670). 387.4–387. 2 indexed citations
11.
Fabiani, Mario, et al.. (1989). Prophylactic and Therapeutic Role of Rioprostil in NSAIDs Induced Gastroduodenal Lesions. Scandinavian Journal of Gastroenterology. 24(sup164). 242–246. 9 indexed citations
12.
Torre, D., et al.. (1988). Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers.. PubMed. 7(6). 382–6. 4 indexed citations
13.
Coletta, Riccardo, et al.. (1988). Etofenamate and transcutaneous electrical nerve stimulation treatment of painful spinal syndromes.. PubMed. 8(4). 295–8. 24 indexed citations
14.
Torre, Donato, et al.. (1987). Plasma fibronectin in head-injured ICU patients. Critical Care Medicine. 15(3). 262–263. 1 indexed citations
15.
Maggiolo, F, et al.. (1986). Prevalence of antibodies to Legionella pneumophila and micdadei in hospitalized children.. PubMed. 65(2). 153–6. 2 indexed citations
16.
Broggini, M, et al.. (1983). Study on the control of hepatitis B virus infection in an institution for the mentally retarded.. PubMed. 62(6). 495–500. 2 indexed citations
17.
Maggiolo, F, et al.. (1982). [Diffusibility of 2 macrolide antibiotics into human extravascular fluids].. PubMed. 29 Suppl 1. 89–101. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026